Speech and language therapy interventions for speech problems in Parkinson's disease

Pauline Campbell*, Scott Rooney, Avril Nicoll, Marian C. Brady, Christina H. Smith, Katherine H.O. Deane, Clare P. Herd, Claire L. Tomlinson, Carl E. Clarke, Catherine M. Sackley

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

Abstract

Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To evaluate the effectiveness of speech and language therapy (SLT) interventions on speech and voice problems in people with Parkinson’s disease. We will investigate whether:. SLT is more effective than no SLT; SLT is more effective than placebo or attention control interventions; one SLT intervention is more effective than another SLT intervention (including standard care).

Original languageEnglish
Article numberCD015009
Number of pages19
JournalCochrane Database of Systematic Reviews
Volume2022
Issue number6
DOIs
Publication statusPublished - 6 Jun 2022

Bibliographical note

Funding Information:
The following people conducted the editorial process for this article. Sign-off Editor (final editorial decision): Robert J Boyle, Cochrane Network Editor. Managing Editor (selected peer reviewers, collated peer-reviewer comments, provided editorial guidance to authors, edited the article): Anne-Marie Stephani, Central Editorial Service. Editorial Assistant (conducted editorial policy checks and supported editorial team): Leticia Rodrigues, Central Editorial Service. Copy Editor (copy-editing and production): Jessica Sharp. Sign-off Editor (final editorial decision): Robert J Boyle, Cochrane Network Editor. Managing Editor (selected peer reviewers, collated peer-reviewer comments, provided editorial guidance to authors, edited the article): Anne-Marie Stephani, Central Editorial Service. Editorial Assistant (conducted editorial policy checks and supported editorial team): Leticia Rodrigues, Central Editorial Service. Copy Editor (copy-editing and production): Jessica Sharp. Peer-reviewers (provided comments and recommended an editorial decision): Dominic Thyagarajan, MD, FRACP, Monash University, Melbourne, Australia (clinical review); Adam Vogel, The University of Melbourne, Australia (clinical review); Robin Featherstone, Cochrane Central Editorial Service (search review); Nuala Livingstone, Cochrane Evidence Production and Methods Directorate (methods review).

Fingerprint

Dive into the research topics of 'Speech and language therapy interventions for speech problems in Parkinson's disease'. Together they form a unique fingerprint.

Cite this